NYHA class II–IV and LVEF ≥40%; NT-proBNP >300 ng/L in SR, >750 ng/L with AF, >1200 ng/L within the last 12 m; regular use of loop diuretics. This evidence concerns the gene NPPB and atrial fibrillation.